Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Thibault

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
The Journal of Infectious Diseases|June 29, 2002
Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver diseaseSophie Hüe, Patrice Cacoub, Christophe Renou, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 15, 2021
Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance dataChristophe Paris, Sophie Perrin, Stephanie Hamonic, et al.
Virology Journal|March 19, 2013
Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative studyVincent Thibault, Catherine Gaudy-Graffin, Philippe Colson, et al.
The Journal of Infectious Diseases|June 19, 2008
Low levels of hepatitis C virus (HCV) neutralizing antibodies in patients coinfected with HCV and human immunodeficiency virusSandrine Castelain, Aurélie Schnuriger, Catherine François, et al.
European Journal of Gastroenterology & Hepatology|December 25, 2004
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis BDominique Thabut, Vincent Thibault, Brigitte Bernard-Chabert, et al.
Vaccine|April 25, 2022
Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workersAnastasia Saade, Leo Cha, Emilie Tadié, et al.
Clinical Chemistry|June 12, 2004
Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis CThierry Poynard, Mona Munteanu, Françoise Imbert-Bismut, et al.
Clinical Chemistry and Laboratory Medicine|April 15, 2004
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donorsFrançoise Imbert-Bismut, Djamila Messous, Vincent Thibault, et al.
Journal of Medical Virology|May 29, 2021
European multicenter evaluation of Xpert® Xpress SARS-CoV-2/Flu/RSV testFemke Wolters, Maria Grünberg, Michael Huber, et al.
Clinical Chemistry|August 26, 2006
A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis CYen Ngo, Mona Munteanu, Djamila Messous, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
The Journal of Infectious Diseases|June 29, 2002
Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver diseaseSophie Hüe, Patrice Cacoub, Christophe Renou, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 15, 2021
Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance dataChristophe Paris, Sophie Perrin, Stephanie Hamonic, et al.
Virology Journal|March 19, 2013
Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative studyVincent Thibault, Catherine Gaudy-Graffin, Philippe Colson, et al.
The Journal of Infectious Diseases|June 19, 2008
Low levels of hepatitis C virus (HCV) neutralizing antibodies in patients coinfected with HCV and human immunodeficiency virusSandrine Castelain, Aurélie Schnuriger, Catherine François, et al.
European Journal of Gastroenterology & Hepatology|December 25, 2004
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis BDominique Thabut, Vincent Thibault, Brigitte Bernard-Chabert, et al.
Vaccine|April 25, 2022
Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workersAnastasia Saade, Leo Cha, Emilie Tadié, et al.
Clinical Chemistry|June 12, 2004
Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis CThierry Poynard, Mona Munteanu, Françoise Imbert-Bismut, et al.
Clinical Chemistry and Laboratory Medicine|April 15, 2004
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donorsFrançoise Imbert-Bismut, Djamila Messous, Vincent Thibault, et al.
Journal of Medical Virology|May 29, 2021
European multicenter evaluation of Xpert® Xpress SARS-CoV-2/Flu/RSV testFemke Wolters, Maria Grünberg, Michael Huber, et al.
Clinical Chemistry|August 26, 2006
A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis CYen Ngo, Mona Munteanu, Djamila Messous, et al.
Pageof 13